Please try another search
Biogened SA is a Poland-based company active in the healthcare sector. The Company is engaged in production and distribution of generic pharmaceuticals in psychiatry, neurology and oncology, as well as development, production and distribution of dermocosmetics and diet supplements. The Company’s product portfolio includes: Polmantis and SST Salvia Stimulating Tablets (pharmaceuticals), Dermedic, Ellexir, Herba Botanic and Novoscabin (dermocosmetics), and Fibers, Prolady, Futimal and Dermedic Caps (diet supplemenst). As of March 31, 2012, Life Science Technologies NV held an 80.92% stake in the capital.
Name | Age | Since | Title |
---|---|---|---|
Sebastian Kostecki | - | 2014 | Member of the Supervisory Board |
Urszula Grzegorzewska | - | 2011 | Chairman of the Supervisory Board |
Marek Mikolajczak | - | 2021 | Member of the Supervisory Board |
Sylwia Grzegorzewska | - | 2021 | Member of the Supervisory Board |
Andrzej Mozyszek | - | 2012 | Member of the Supervisory Board |
Elzbieta Mikolajczak | - | 2014 | Member of the Supervisory Board |
Anna Kowalska | - | 2012 | Member of the Supervisory Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review